A new publication titled "New and emerging somatostatin therapies for neuroendocrine tumors: 'what is in the pipeline'" appeared on September 16, 2026. The article was published in Expert Opinion on Pharmacotherapy. It is listed under PubMed ID 42745679. The publication is described as covering new and emerging somatostatin-related therapies for neuroendocrine tumors, according to its title. No additional details, findings, or data points were provided in the event record. This entry reflects only the publication's title, journal, and date as recorded. Readers interested in vasoactive intestinal peptide, which is related to somatostatin pathway research, can consult the compound overview for further background and context on its approved regulatory status.
New Publication Reviews Emerging Somatostatin Therapies for NETs
See the full vasoactive intestinal peptide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42745679/